Florence, ItalySIRS 2026 Oral Presentation – LB-102 for Acute Schizophrenia in Adults Results From the Phase 2 NOVA1 Clinical Trial, With a Focus on PANSS Marder Factor Scores
SIRS 2026 Poster Presentation – LB-102 for cognition in patients with schizophrenia: an exploratory post hoc analysis from a randomised, double-blind, placebo-controlled phase 2 study
